Dynamic Technology Lab Private LTD Morphic Holding, Inc. Transaction History

Dynamic Technology Lab Private LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$19.95 - $31.0 $75,091 - $116,684	3,764 Added 39.25%	13,354 $386,000
Q3 2023 Nov 14, 2023	BUY	$21.33 - $59.42 $71,242 - $198,462	3,340 Added 53.44%	9,590 $220,000
Q2 2023 Aug 14, 2023	SELL	$34.33 - $62.11 $338,837 - $613,025	-9,870 Reduced 61.23%	6,250 $358,000
Q1 2023 May 12, 2023	BUY	$26.01 - $48.69 $419,281 - $784,882	16,120 New	16,120 $607,000
Q3 2022 Nov 14, 2022	BUY	$22.23 - $33.37 $44,904 - $67,407	2,020 Added 16.17%	14,510 $411,000

Q2 2022 Aug 12, 2022	BUY	$19.74 - $43.01 $246,552 - $537,194	12,490 New	12,490 $271,000
Q3 2021 Nov 15, 2021	SELL	$53.61 - $67.5 $394,033 - $496,125	-7,350 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$45.13 - $64.99 $331,705 - $477,676	7,350 New	7,350 $422,000

142

37.9M

13.5K

190K

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $1.31B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.